These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21797890)

  • 21. Mismatch negativity is not correlated with neuroendocrine indicators of catecholaminergic activity in healthy subjects.
    Hansenne M; Pinto E; Scantamburlo G; Couvreur A; Reggers J; Fuchs S; Pitchot W; Ansseau M
    Hum Psychopharmacol; 2003 Apr; 18(3):201-5. PubMed ID: 12672172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine effects of citalopram infusion in anorexia nervosa.
    Mondelli V; Gianotti L; Picu A; Abbate Daga G; Giordano R; Berardelli R; Pariante CM; Fassino S; Ghigo E; Arvat E
    Psychoneuroendocrinology; 2006 Nov; 31(10):1139-48. PubMed ID: 17045409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoaminergic regulation of neuroendocrine function and its modification by cocaine.
    Levy AD; Baumann MH; Van de Kar LD
    Front Neuroendocrinol; 1994 Jun; 15(2):85-156. PubMed ID: 7813744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The biological basis of suicidal behavior: neuroendocrine and psychophysiological approach to the role of catecholamines].
    Pitchot W; Hansenne M; Gonzalez Moreno A; Wauthy J; Ansseau M
    Acta Psychiatr Belg; 1995; 95(4-5):210-33. PubMed ID: 8525861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The neuroendocrine aspects of chronic alcoholism: the effect of alcohol intake and its withdrawal].
    Fonzi S; Murialdo G; Bo P; Filippi U; Costelli P; Parodi C; Maurelli M; Polleri A; Savoldi F
    Ann Ital Med Int; 1992; 7(2):87-94. PubMed ID: 1467129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India.
    Chittiprol S; Kumar AM; Satishchandra P; Taranath Shetty K; Bhimasena Rao RS; Subbakrishna DK; Philip M; Satish KS; Ravi Kumar H; Kumar M
    Psychoneuroendocrinology; 2008 Jan; 33(1):30-40. PubMed ID: 17993249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blunted growth hormone response is associated with early relapse in alcohol-dependent patients.
    Heinz A; Dettling M; Kuhn S; Dufeu P; Gräf KJ; Kürten I; Rommelspacher H; Schmidt IG
    Alcohol Clin Exp Res; 1995 Feb; 19(1):62-5. PubMed ID: 7771665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further neuroendocrine evidence for reduced D2 dopamine receptor function in alcoholism.
    Balldin J; Berggren U; Lindstedt G; Sundkler A
    Drug Alcohol Depend; 1993 Apr; 32(2):159-62. PubMed ID: 8508726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychopathology in alcohol withdrawal: relationship to alpha2-adrenoceptor function.
    Fahlke C; Berggren U; Lundborg C; Balldin J
    Alcohol Alcohol; 1999; 34(5):750-9. PubMed ID: 10528818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of dieting and weight loss on neuroendocrine responses to tryptophan, clonidine, and apomorphine in volunteers. Important implications for neuroendocrine investigations in depression.
    Goodwin GM; Fairburn CG; Cowen PJ
    Arch Gen Psychiatry; 1987 Nov; 44(11):952-7. PubMed ID: 3675135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine measures of dopaminergic function in chronic cocaine users.
    Lee MA; Bowers MM; Nash JF; Meltzer HY
    Psychiatry Res; 1990 Aug; 33(2):151-9. PubMed ID: 2243892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone responses to citalopram in abstinent alcohol dependent subjects.
    Gotjen D; Szabo Z; Lee S; Wand G
    Alcohol Clin Exp Res; 2002 Nov; 26(11):1625-31. PubMed ID: 12436050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans.
    Berardelli R; Margarito E; Ghiggia F; Picu A; Balbo M; Bonelli L; Giordano R; Karamouzis I; Bo M; Ghigo E; Arvat E
    J Endocrinol Invest; 2010 Oct; 33(9):657-62. PubMed ID: 20414043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tobacco use is associated with reduced central serotonergic neurotransmission in type 1 alcohol-dependent individuals.
    Berggren U; Fahlke C; Eriksson M; Balldin J
    Alcohol Clin Exp Res; 2003 Aug; 27(8):1257-61. PubMed ID: 12966319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between central serotonergic neurotransmission and reduction in alcohol intake by citalopram.
    Berggren U; Eriksson M; Fahlke C; Balldin J
    Drug Alcohol Depend; 2001 Aug; 63(3):263-7. PubMed ID: 11418230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noradrenergic and dopaminergic interrelation in schizophrenia.
    Brambilla F; Marini S; Saito A; Fassone G; Picardi A; Nerozzi D; Pancheri P
    Psychiatry Res; 1994 Sep; 53(3):231-42. PubMed ID: 7870845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia.
    Tancer ME; Mailman RB; Stein MB; Mason GA; Carson SW; Golden RN
    Anxiety; 1994-1995; 1(5):216-23. PubMed ID: 9160577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroendocrine responses to fenfluramine and its relationship to personality in alcoholism.
    Weijers HG; Wiesbeck GA; Jakob F; Böning J
    J Neural Transm (Vienna); 2001; 108(8-9):1093-105. PubMed ID: 11716144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine evidence for reduced serotonergic neurotransmission during heavy drinking.
    Balldin J; Berggren U; Engel J; Eriksson M
    Alcohol Clin Exp Res; 1994 Aug; 18(4):822-5. PubMed ID: 7978090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral application of citalopram (20 mg) and its usefulness for neuroendocrine challenge tests.
    Henning J; Netter P
    Int J Neuropsychopharmacol; 2002 Mar; 5(1):67-71. PubMed ID: 14609009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.